Congress considers $650 million imaging bill for prostate cancer
If Congress accepts the recommendations of the AdMeTech Foundation, which appealed for new ways to perform, diagnose, biopsy and treat prostate cancer patients, the new legislation would authorize $650 million for prostate cancer imaging research and education. The AdMeTech Foundation made the appeal to Congress during its conference in Washington, D.C. last week.

More powerful MR imaging magnets and MR-guided devices may offer a path to prostate cancer diagnosis improvements, according to Clare Tempany, MD, a professor of radiology at Harvard Medical School.

Maryland Democrats Reps. Elijah Cummings and Albert Wynn have drafted a House version of the Prostate Research Imaging and Men's Education Act. In June, Sen. Barbara Boxer (D-CA) proposed the act in the Senate, with Sens. Frank Lautenberg (D-NJ) and John Kerry (D-MA) as cosponsors. Cummings and Rep. Dan Burton (R-IN) previously championed HR 353, calling for more federal research funding for prostate imaging.

The current House bill would appropriate $130 million a year over five years to fund research and development imaging technologies to diagnose and treat prostate cancer. It will also authorize $10 million for an educational campaign to raise awareness about screenings.
The House bill has 50 bipartisan cosponsors.

AdMeTech is a nonprofit organization, which identifies, funds and administers research and development projects to expedite the advancement of technologies that can improve the diagnosis and treatment of life-threatening and widespread diseases.